4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-17-032409
CIK 0001660719operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 9:51 PM ET
Size
7.9 KB
Accession
0001104659-17-032409
Insider Transaction Report
Form 4
Harris Robert Paul
Director
Transactions
- Award
Common Shares, without par value
2017-05-11+7,500→ 601,594 total - Award
Director Stock Option (right to buy)
2017-05-11+15,000→ 15,000 totalExercise: $1.56Exp: 2017-05-11→ Common Shares, without par value (15,000 underlying)
Holdings
- 600,188(indirect: By Spouse)
Common Shares, without par value
Footnotes (3)
- [F1]Restricted Stock Units, all of which vest on May 11, 2018, subject to the director's continued service on the Board as of such date.
- [F2]Includes 594,094 shares of Common Stock and 7,500 Restricted Stock Units.
- [F3]The option vests in one installment on May 11, 2018, subject to the director's continued service on the Board as of such date.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 9:51 PM ET
- Size
- 7.9 KB